fbpx
January 30, 2025

Novo Nordisk Will Test CagriSema’s Long-term Efficacy in Late-stage Trial, Clinicaltrials.gov Entry Shows Novo Nordisk Will Test CagriSema’s Long-term Efficacy in Late-stage Trial, Clinicaltrials.gov Entry Shows

LONDON (Reuters) – Novo Nordisk will begin a late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10 to test its long-term efficacy, according […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0